Latest Guillain-Barre syndrome Stories
Intravenous immune globulin (IVIg) is an effective treatment for certain disorders of the nerve and muscles, including Guillain-Barré syndrome (GBS) and a form of neuropathy called chronic inflammatory demyelinating polyneuropathy (CIDP).
The deVere Group, the world's largest independent financial consultancy group has raised £72,030 in funds towards Combat Stress, Guillain-Barre syndrome support group, as well as Inspire, from world-wide sponsors including deVere partners and deVere staff.
MADISON, Wis., Nov. 5, 2010 /PRNewswire/ -- Armed with the latest information, physicians can diagnose patients with Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) more easily and earlier, increasing the chances of successful recovery.
KING OF PRUSSIA, Pa., Oct. 29 /PRNewswire/ -- To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards.
NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010.
NARBERTH, Pa., June 23 /PRNewswire/ -- The GBS/CIDP Foundation International today announced the designation of seven initial "Centers of Excellence" for the diagnosis and treatment of Guillain-Barre syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and variants. The centers will form a network of healthcare facilities to provide expert diagnosis and management of inflammatory neuropathies for patients who are unable to consult with medical experts in the field in...
NARBERTH, Pa., June 17 /PRNewswire/ -- The GBS/CIDP Foundation International, the only non-profit organization dedicated to serving patients afflicted with Guillain-Barre Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and variants, announced the appointment of Patricia A.
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN